{"disease":{"id":"prophylaxis-influenza","name":"prophylaxis influenza"},"drugs":{"marketed":[{"drug_id":"baloxavir","indication_name":"Post-exposure prophylaxis of influenza","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xofluza","generic_name":"BALOXAVIR","company_name":"Genentech Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":52,"revenue":null,"mechanism":"Xofluza works by inhibiting the endonuclease activity of the influenza virus, preventing it from replicating."},{"drug_id":"baloxavir","indication_name":"Post-Exposure Prophylaxis of Influenza","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xofluza","generic_name":"BALOXAVIR","company_name":"Genentech Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":52,"revenue":null,"mechanism":"Xofluza works by inhibiting the endonuclease activity of the influenza virus, preventing it from replicating."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}